{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:24Z","timestamp":1762265244462,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.regg.2025.101720","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:59:49Z","timestamp":1756303189000},"page":"101720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uso racional de antipsic\u00f3ticos en pacientes mayores: un abordaje cualitativo"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-6419","authenticated-orcid":false,"given":"Mar\u00eda Noelia","family":"Vivacqua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-8230","authenticated-orcid":false,"given":"Mar\u00eda Florencia","family":"Grande Ratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regg.2025.101720_bib0145","article-title":"Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia","volume":"12","author":"M\u00fchlbauer","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.regg.2025.101720_bib0150","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.regg.2025.101720_bib0155","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1136\/heartjnl-2017-312107","article-title":"Cardiovascular effects of psychotic illnesses and antipsychotic therapy","volume":"105","author":"Howell","year":"2019","journal-title":"Heart."},{"key":"10.1016\/j.regg.2025.101720_bib0160","doi-asserted-by":"crossref","DOI":"10.51987\/evidencia.v26i1.7032","article-title":"Criterios de Beers para identificar el consumo de medicaci\u00f3n potencialmente inapropiada: adaptaci\u00f3n para su aplicaci\u00f3n en Argentina","volume":"25","author":"Calabro","year":"2022","journal-title":"Evidencia, actualizacion en la pr\u00e1ctica ambulatoria."},{"key":"10.1016\/j.regg.2025.101720_bib0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.31053\/1853.0605.v78.n3.32653","article-title":"Prevalencia en la prescripci\u00f3n de antipsic\u00f3ticos y monitoreo metab\u00f3lico en pacientes bajo tratamiento cr\u00f3nico","volume":"78","author":"Vivacqua","year":"2021","journal-title":"Rev Fac Cien Med Univ Nac Cordoba."},{"key":"10.1016\/j.regg.2025.101720_bib0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12888-021-03162-w","article-title":"Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use","volume":"21","author":"Brouwer","year":"2021","journal-title":"BMC Psychiatry."},{"key":"10.1016\/j.regg.2025.101720_bib0175","unstructured":"Sociedad Espa\u00f1ola de Psicogeriatr\u00eda [Internet]. [consultado 24 May 2025]. Disponible en: https:\/\/www.sepg.es\/documentoantipsicoticos."},{"key":"10.1016\/j.regg.2025.101720_bib0180","article-title":"Barriers to Somatic Health Care for Persons With Severe Mental Illness in Belgium: A Qualitative Study of Patients\u2019 and Healthcare Professionals\u2019 Perspectives","volume":"12","author":"Kohn","year":"2021","journal-title":"Front Psychiatry."},{"key":"10.1016\/j.regg.2025.101720_bib0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12888-020-02990-6","article-title":"Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review","volume":"20","author":"Ali","year":"2020","journal-title":"BMC Psychiatry."},{"key":"10.1016\/j.regg.2025.101720_bib0190","unstructured":"World Health Organization. Uso racional de los medicamentos: progresos realizados en la aplicaci\u00f3n de la estrategia farmac\u00e9utica de la OMS. [Internet] [consultado 17 Jul 2024]. Disponibles en: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB118\/B118_6-sp.pdf."},{"key":"10.1016\/j.regg.2025.101720_bib0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/YIC.0000000000000102","article-title":"Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studies","volume":"31","author":"Brody","year":"2016","journal-title":"Int Clin Psychopharmacol."},{"key":"10.1016\/j.regg.2025.101720_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218711","article-title":"Mental health professionals\u2019 views and experiences of antipsychotic reduction and discontinuation","volume":"14","author":"Cooper","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.regg.2025.101720_bib0205","series-title":"Basics of Qualitative Research","first-page":"457","author":"Corbin","year":"2015"},{"key":"10.1016\/j.regg.2025.101720_bib0210","first-page":"154","article-title":"Difficulties in monitoring cardiometabolic risk in the chronic use of atypical antipsychotics for non-traditional indications, in a specialty hospital in Argentina: a qualitative study","volume":"95","author":"Vivacqua","year":"2025","journal-title":"Arch Cardiol Mex."},{"key":"10.1016\/j.regg.2025.101720_bib0215","article-title":"Monitoring of Metabolic Adverse Effects Associated With Atypical Antipsychotics Use in an Outpatient Psychiatric Clinic","author":"Pereira","year":"2018","journal-title":"J Pharm Pract [Internet]."},{"key":"10.1016\/j.regg.2025.101720_bib0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.pra.0000435035.45308.03","article-title":"Metabolic monitoring of patients prescribed second-generation antipsychotics","volume":"19","author":"Dhamane","year":"2013","journal-title":"J Psychiatr Pract."},{"key":"10.1016\/j.regg.2025.101720_bib0225","unstructured":"Psychology Today. Perceptions and their impact on behavior. [Internet] [consultado 3 Nov 2024]. Disponible en: https:\/\/www.psychologytoday.com\/intl\/basics\/perception."},{"key":"10.1016\/j.regg.2025.101720_bib0230","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s12325-022-02075-8","article-title":"Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis","volume":"39","author":"Yunusa","year":"2022","journal-title":"Adv Ther."},{"key":"10.1016\/j.regg.2025.101720_bib0235","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.regg.2025.101720_bib0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.regg.2025.101720_bib0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing."},{"key":"10.1016\/j.regg.2025.101720_bib0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40266-022-00992-5","article-title":"Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update","volume":"40","author":"Rogowska","year":"2023","journal-title":"Drugs Aging."},{"key":"10.1016\/j.regg.2025.101720_bib0255","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2012.476","article-title":"Choosing wisely: helping physicians and patients make smart decisions about their care","volume":"307","author":"Cassel","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.regg.2025.101720_bib0260","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s12877-023-04429-5","article-title":"Clinical competence, communication ability and adherence to choosing wisely recommendations for lipid reducing drug use in older adults","volume":"23","author":"Tamblyn","year":"2023","journal-title":"BMC Geriatr."},{"first-page":"220","year":"2016","series-title":"The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia","key":"10.1016\/j.regg.2025.101720_bib0265"},{"key":"10.1016\/j.regg.2025.101720_bib0270","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/JGP.0b013e318209dd24","article-title":"Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study","volume":"19","author":"Lipscombe","year":"2011","journal-title":"Am J Geriatr Psychiatry."},{"key":"10.1016\/j.regg.2025.101720_bib0275","article-title":"Glucose Metabolism Neural Cell Senescence and Alzheimer's Disease","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci [Internet]."},{"key":"10.1016\/j.regg.2025.101720_bib0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer's disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.regg.2025.101720_bib0285","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care."}],"container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X25001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X25001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:02:36Z","timestamp":1762264956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211139X25001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0211139X25001003"],"URL":"https:\/\/doi.org\/10.1016\/j.regg.2025.101720","relation":{},"ISSN":["0211-139X"],"issn-type":[{"type":"print","value":"0211-139X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uso racional de antipsic\u00f3ticos en pacientes mayores: un abordaje cualitativo","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regg.2025.101720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEGG. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101720"}}